Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-31

Clinical Trial Update: Xiaflex® Plus Testosterone Treatment Pilot Study Protocol [Phase 4]

View source ↗

Summary

Phase 4 pilot study protocol update evaluating Xiaflex with testosterone treatment for Peyronie's Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • XIAFLEX (Collagenase Clostridium histolyticum)
  • testosterone treatment (testosterone)

Snippet

Sponsor: Men's Health Boston | Conditions: Peyronie's Disease (PD) | Phase 4 | Status: COMPLETED